Correvio Reports Third Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/14/2026
- Wall St slides as hot CPI data fuels rate-hike bets; chips, banks weigh
- Oil prices steady after gains on Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Correvio Pharma (CORV) Misses Q3 EPS by 6c, Revenues Miss
November 14, 2019 7:03 AM ESTCorrevio Pharma (NASDAQ: CORV) reported Q3 EPS of ($0.23), $0.06 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $6.67 million versus the consensus estimate of $8.82 million.
"On the commercial front, our marketed products portfolio has generated $21.3 million year-to-date in 2019, with $6.7... More



